ReShape Lifesciences implements 1-for-25 reverse stock split effective May 9, 2025

Vyome Holdings, Inc

Reverse stock split at 1-for-25 ratio effective at trading open on May 9, 2025; each 25 shares become 1.
Stockholders approved the split at special meeting on April 1, 2025; fractional shares rounded up.
Authorized shares unchanged; proportional adjustments to warrants, options, and convertible preferred.
New CUSIP for post-split common stock is 76090R408.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Vyome Holdings, Inc: Filed Certificate of Amendment to effect a 1-for-25 reverse stock split of common stock (effective 2025-05-06).

Change: charter amendment
Effective: 2025-05-06

Exact text from the filing

On May 6, 2025, ReShape Lifesciences Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) to its Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), with the Secretary of State of the State of Delaware to effect a 1-for-25 reverse split of the Company’s outstanding common stock, $0.001 par value per share (the “Reverse Stock Split”).

View on SEC.gov

Browse all governance changes →

Vyome Holdings, Inc filing history →

Source: SEC EDGAR

accession 0001104659-25-046717

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.